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Abstract
Hydrogels are emerging as an important source for current biomaterial design, as they often 
possess intrinsic physical and mechanical similarities with soft tissue, are non-toxic and 
biocompatible. However, many hydrogel-based biomimetic materials are either derived from 
limited sources, or require external activators to achieve functionality, such as chemical 
crosslinking or environmental cues. Furthermore, many cross-linkers used with hydrogels are 
toxic, and environmental cues invoke slow responses. Therefore, to function as a rational 
biomaterial design for a biomedical application, these properties are preferably avoided, or 
improved with a composite system containing two or more polymer components to overcome 
these limitations.
Plant-derived nanofibrillar cellulose (NFC) possesses the same intrinsic properties as many 
other hydrogels derived from the components of extracellular matrices (ECM). Therefore, NFC 
shares the biocompatibility and non-toxicity aspects of biomimetic materials. However, 
additional features of NFC can be exploited, such as shear-thinning properties, spontaneous 
self-gelation and chemical modification capabilities. Additionally, the source of NFC is 
practically inexhaustible, and is environmentally biodegradable, bearing no ecological burden.
Therefore, when designing hydrogel-based biomaterials, NFC offers versatility, which enables 
the fabrication of potential biomedical applications for various purposes in an environmentally 
safe way.
In this thesis, a wide range of potential applications of NFC-based hydrogels were investigated. 
These include 3D cell culturing, in vivo implantation and coating systems for drug and cell 
delivery, controlled drug delivery and local delivery as a bioadhesive system. These methods 
offer insight into the versatility of NFC-based hydrogels, which could improve the future design 
of biomaterials, for a safer and more efficient use in biomedical applications.
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1 Introduction
A biomaterial can be classified basically as any material that interacts or is in contact with living 
surroundings, such as tissue or cells. The use of biomaterials date all the way back to the ancient 
Egypt, where archeological findings have revealed possibly the first prosthesis with functional 
properties [1]. An anatomically correct wooden big toe was crafted and implemented with 
surgical expertise to allow the patient to move normally. The added function of the biomaterial 
construct would therefore allow it to be classified as the first biomedical device. Biomedical 
devices take advantage of engineering sciences to fabricate and deploy biomaterials for 
healthcare purposes. This leads to the field of biomedical engineering, where engineering and 
medicine are considered as the two sides of the same coin. It is an interdisciplinary field, where 
biomedical devices are designed and utilized in therapeutics, diagnostics and tissue 
engineering. However, we are no longer bound to metal, wood and leather, and new 
biomaterials and their applications emerge constantly, with personalized functionality and 
structural design that also resembles the original human physiology [2].
It can be rationalized that to reach the optimal biomedical device functionality, it would be 
preferable to imitate the original tissue function as closely as possible, which the device is 
designed to repair or replace. However, different tissues have different characteristics. 
Therefore, there is no universal option to solve the problem. Additionally, the extracellular 
matrix (ECM) is dynamic, and is affected by various factors at various times [3]. And as such, 
the literature on various biomaterials and their usage is vast; therefore, this thesis focuses 
mainly on three themes, which can be considered as the core elements of the literature review 
part. The key aspects are the current technologies and methods, such as humanized animal 
models and microfluidics, that are used to mimic human physiology and to study the biological 
processes and disease states. This is important for understanding the underlying phenomena in 
designing the biomedical devices and their applications. The biomaterial designs used in these 
applications need to resemble the microenvironment they are targeted at. The focus is in safe 
and efficient treatments, such as limiting host responses and achieving physiological 
functionality. The main discussion follows the biomaterial design based on hydrogels, as they 
are one of the main source of novel biomedical devices [4,5]. As this thesis is specifically aimed 
at exploring the use of hydrogels based on plant-derived native nanofibrillar cellulose (NFC) 
and anionic carboxylated nanofibrillar cellulose (ANFC), the final theme is focused on the 
literature of these biopolymers in the biomedical field.
Cellulose-based materials, NFC and ANFC are generally considered as safe, biocompatible and 
non-toxic biomaterials, with low cost and a renewable source [6]. The architecture of cellulose 
follows a hierarchical path from the plant tissue all the way to individual cellulose molecules. 
NFC is usually derived from plant ECM, where the individual crystalline cellulose microfibrils 
are isolated from the raw material. Single microfibrils (i.e. nanofibrils) are typically 3-4 nm in 
diameter and consists approximately 30-40 cellulose polysaccharide chains [7]. Therefore, NFC 
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is a finely structured hydrogel composed of single isolated cellulose microfibrils. And because 
of the hydrogel nature, NFC has a very high content of water, which is bound within the matrix 
by strong hydrogen bonding to the hydroxyl groups present in the cellulose molecules. 
Therefore, NFC has some intrinsic resemblance to soft tissue mechanically, which enables cell 
culturing in a natural 3D in vivo-like environment [8,9]. Additionally, NFC has extensive 
chemical modification capabilities, due to the available functional hydroxyl groups. These
properties make NFC an excellent candidate for potential hydrogel-based biomedical device 
applications.
The experimental section of this thesis considers, evaluates and characterizes different types of 
potential pharmaceutical and biomedical applications for NFC-based hydrogels, such as 3D 
organoid development, injectable implant, surgical suture coating, controlled drug release 
application and bioadhesive film formulation. The main aspect focuses on the use of NFC and 
ANFC by themselves or as a combination of functional natural materials, such as alginate, 
pectin and mucin, without the need for toxic cross-linkers. Materials and their combinations are 
characterized by their rheological properties and in vitro/in vivo suitability, with some 
consideration about their mechanical properties. Drug release and cell carrier properties are 
investigated in addition to surface interactions, such as cell attachment, cell encapsulation and 
bioadhesion.
The aim was to develop rational, safe and efficient applications for the purpose of improved 
healthcare. The advantages and limitations of the NFC-based applications are discussed and 
compared with other studies available in literature in their respective experimental sections. 
These applications could potentially improve the therapeutic delivery of drugs and cells to their 
target locations, which take advantages of NFC characteristics and established treatment 
methods, such as surgical suturing, minimal-invasive and non-invasive administration. 
Therefore, it is my opinion that the combination of established methodology and the use of 
NFC-based materials would prove useful in designing new biomaterials for various biomedical 
application purposes.
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2 Mimicking the in vivo environment 
 
In vitro methods have a long history in biomedical research, and have been widely developed 
and utilized to enable isolated experimental systems, such as cell and tissue cultures [10]. These 
are designed to function as convenient and simple representations of physiological aspects 
under study; however, the correlation between the in vitro experiment and the physiological 
response of a fully functional and complex organism remains a challenge [11]. The differences 
between in vivo and in vitro environment have therefore been acknowledged, and new methods 
have been investigated to bridge the gap in between [12]. These differences can be categorized 
in some key elements (Figure 1), which represent various cues in the extracellular 
microenvironment that regulate cell behavior, such as cell differentiation, proliferation, 
migration, adhesion and polarity [13]. These elements may also change with time, which 
generates a dynamic environment in contrast to the static conditions often present in in vitro 
methods. 
 
 
Figure 1. Key factors affecting cell behavior. Chemical, physical (static) and mechanical 
(dynamic) cues in the microenvironment trigger various cellular responses. 
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The key elements affecting cell behavior are either chemical, physical or mechanical [3,14,15].
Biochemical and physical cues also provide a gradient, which in turn can be linear or non-linear 
[16]. Examples of chemical gradients are oxygen, hormones or other soluble factors, which can 
affect cell behavior. Physical and mechanical cues relate to the extracellular surroundings, 
which the cell can sense and interact through integrin mediated signal transduction [17].
Examples of physical cues are surface topology [18], density [19] and porosity [20], and for 
mechanical cues, hardness/softness [21] and stiffness [22]. Additionally, tissue functions can 
trigger mechanical cues, for example tissue deformation (e.g. the compressive forces of the gut) 
[23] or the shear forces of the blood flow [24,25]. These cues provide a complex system for 
guiding cell behavior, such as migration, adhesion, proliferation, apoptosis and differentiation.
Many elements in the microenvironment can interact in numerous ways, for example cell-cell 
or cell-ECM interactions can be both chemical and physical [26-30]. All these various cues and 
interactions contribute to the development [31] and maintenance of a complex system (i.e. 
homeostasis) [32]. Additionally, these cues need to be controlled spatially and temporally to 
achieve better correlation with physiological responses. Currently, in vitro methods cannot 
reproduce the complexity of an intact organism, and therefore the output of the method is 
always limited due to the lack of physiological characteristics. This sets an imposing challenge, 
not only to understand all the underlying physiological mechanisms and the dynamic 
interactions within the whole system, but also to reproduce them. Fortunately, there is an 
increasing interest in pursuing these challenges and recently many attempts have been made to 
improve the correlation between in vitro and in vivo [33-38]. For example, several microfluidic 
systems have been developed to help overcome some of these challenges [39-41].
Microfluidics
Microfluidics combined with microchip technologies enable the control over many elements 
necessary to mimic physiological environments [42]. These systems are often termed as 
“human-on-a-chip”, or “organs-on-a-chip”. These devices allow continuous, real-time analysis 
and imaging of cell cultures. Typically, most microfluidic devices are fabricated with the soft 
lithography method, which is an extension of photolithography [43]. First a photo-sensitive 
material (a.k.a. photoresist), such as resin, is deposited on a silicon wafer (i.e. the substrate). 
The thickness of the resin layer determines the sizes of the micro-channels, which usually range 
from a few hundred nanometers to tens of micrometers. On top of the resin is placed a protective 
layer, a photomask, which includes the micro-channel pattern etched on the mask. The 
photomask is then exposed to UV light, which cures the resin at the unprotected areas of the 
photomask, i.e. the micro-channel pattern. The protective mask is removed and the uncured 
resin is dissolved leaving a master mold, which can be further used in soft lithography. Soft 
lithography utilizes a wide variety of elastomeric materials, most commonly 
polydimethylsiloxane (PDMS). Advantages of PDMS are biocompatibility, transparency, ease 
of use and low cost. The molding process begins with PDMS solution deposited on top of the 
master mold acquired by photolithography. PDMS is cross-linked, for example with a 
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hydrosilylation reaction [44], to harden the solution into a PDMS block. Once the block is 
obtained, it can be further modified with tube connectors, such as inlet and outlet drilling or 
punching. The device is completed when the block is placed typically on top of a glass slide 
and closed off with plasma bonding. Afterwards the device can be connected to pumps and 
reservoirs, or combined with other microfluidic devices.
Microfluidic cell culture devices provide temporal control in the system, including a chemical 
gradient with mechanical forces, such as fluidic shear and compression [43]. Specific responses 
can be analyzed in single cell- and co-cultures, in addition to recreating interfacial processes 
such as the blood-brain-barrier [45]. The model was capable of mimicking blood-brain-barrier 
physiology with frequent flow fluctuation for up to 10 days with well-organized tight junctions 
and morphology of brain microvascular endothelial cells (BMECs) already on day 3. Therefore, 
an important aspect in mimicking physiological conditions is precise flow control. Flow control 
can be achieved through switching between efficient mixing turbulent flows and minimal 
mixing laminar flows in a series of channels to create gradients. Fluid-to-cell ratios can be 
designed to match physiological conditions to mimic physiologically relevant extracellular 
environments, which assist in tissue development. For example, C2C12 myoblasts were 
induced into different states of cell differentiation with a microfluidic system [46]. Microfluidic 
devices can also be designed to function autonomously, or as self-regulating systems [47]. For 
example, it was shown that the cell protein concentration could be precisely controlled with the
feedback-loop parameters regulating the loop response dynamics [48], which are one of the 
most important mechanisms in maintaining homeostasis.
Microfluidics offers a variety of means to improve therapeutic strategies with artificially 
recreated biological complexes. Therefore, the biomaterial design of hydrogels can be also 
improved with advanced microfluidic systems modeling the in vivo environment. A single cell 
capture system was shown to be effective in detecting circulating tumor cells [49]. The system 
was designed to restrict cell flow in a mixed population to hold and trap cells of interest 
selectively. A strong correlation was found between the device and tumor biopsies, indicating 
a physiologically relevant sampling and diagnostics method. Although the device did not mimic 
a specific organ or organs to create the artificial environment, however, such devices have been 
investigated [50]. A multi-organ system was designed to mimic metastasis formation in a lung 
cancer model. Human bronchial epithelial (16HBE) cells were cultured at the primary site, and 
three separate downstream cultures consisted of astrocytes, osteoblasts and hepatocytes. Lung 
cancer cells were introduced with the 16HBE cells and allowed to grow at the primary site. The 
invasion to downstream sites (brain, bone and liver) was then investigated. The metastasis 
progression was effectively recreated and analyzed in a system, which mimicked the 
physiological characteristics of multiple living organs. Stem cell research has also benefited 
from microfluidics. Stem cell differentiation responses can be detected with graded 
concentration ranges of growth factors [51]. Advantages of such devices are the use of single 
culture systems, which enable the precise optimization of stem cell use in tissue engineering 
and transplantation. Recently, stem cell applications have been combined with functional 
hydrogels [52]. Precisely sculpted or designed 3D structures enable biochemically and 
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physically relevant environments, i.e. microgels, which can be further tailored with 
microfluidics, especially with the use of stem cells that are known to be highly sensitive to their 
surroundings (Figure 2). Functional microgels and -fluidics combined can provide efficient and 
precise tools to construct complex biological settings to mimic in vivo microenvironments, 
which could aid in the design of more advanced biomaterials and biomedical devices. 
 
 
Figure 2. A simplified schematic of a microfluidic “organs-on-a-chip”. The chip contains 
multiple organs represented by their respective chambers. Each chamber can house cells in 
various states of differentiation. The cells can be seeded individually, as co-cultures or 
patterned in multiple ways. Microgels can be implemented with various properties to mimic 
different organ characteristics. Fluid flow can be adjusted in individual channels with a flow 
control system, which also controls the peripheral cell-signaling gradient between the 
chambers (e.g. a feedback loop). And finally, analysis can be made in-line or individually from 
the outlet of each chamber. For example, such designs can potentially improve the 
understanding of the mechanisms in disease onset and pathogenesis. Organs-on-a-chip 
microfluidic systems could potentially advance the designing of biomedical devices for the 
treatment of various diseases. 
Humanized animal models 
Despite the advantages of microfluidics and stem cell research, using cell or tissue samples 
from human donors is not without its problems, such as ethical and logistical issues. Humanized 
animal models can provide alternative ways to achieve physiologically relevant information 
[53], which, as was discussed with microfluidics, also assist in the development of hydrogel 
biomaterials for biomedical purposes. The development of humanized mice has occurred in 
three consequent breakthroughs, beginning with the inactivation of the immune system of mice 
[54]: (i) the discovery of severe immunodeficiency (scid), facilitated by a PRKDC (protein 
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kinase DNA-activated catalytic polypeptide) gene mutation in CB17 mice, which enabled host 
mice to be relatively receptive towards heterologous cell transplantations; (ii) the development 
of non-obese diabetic NOD-scid mice, allowing higher levels of engraftment with the decrease 
of host NK-cell activity; (iii) targeted mutations at interleukin-2 receptor gamma chain 
(IL2rgnull), which disabled several interleukin cytokine receptor activations, resulting in a lack 
of adaptive immunity and absence of NK-cells. The most commonly used strains of mice 
concerning the breakthroughs above are NSG, NOG and BRG [55]. These strains have been 
shown to model physiological responses more accurately than any earlier strain.
The incorporation of the human immune system in the animal is then enabled, as the strain 
(host) immune system has been severely compromised. There are three typical models of 
humanization [55]. Human peripheral leukocytes are injected into the host Hu-PBL-SCID 
model. The method is excellent for T cell function investigation, but with a drawback of 
relatively short experimental window. In the Hu-SCR-SCID model, human CD34+ 
hematopoietic stem cells are administered intravenously. This provides the model with a 
complete human immune system; however, bone marrow generated cells are detected at lower 
levels. The third model, aptly nicknamed as the “BLT” (bone marrow, liver and thymus), 
utilizes human fetal liver and thymus transplants at the host kidney with an injection of human 
CD34+ hematopoietic stem cells. A fully functional human immune system is developed 
(including a mucosal immune system), but this model also suffers from a restricted 
experimental window. 
Specific models are therefore required depending on the study needs. However, numerous 
studies have already been performed with the above-mentioned strain and model combinations. 
For example, a major field of investigation is infectious diseases such as HIV, in which the 
BLT model especially has proven valuable due to the functioning human mucosa enabling the 
use of both vaginal and rectal transmission routes [56]. Early viral infection dynamics can be 
investigated, which allows the evaluation of therapeutic prevention in addition to treatment and 
potential eradication. Another example is Plasmodium falciparum (malaria) where the full life 
cycle of the parasite could be replicated [57]. This enables the study of human infected species 
in animals with specific responses to treatments that reflect human physiology. Incidentally, 
the investigation of infectious diseases has also led to new discoveries. In a study of NSG Hu-
SRC-SCID infected with influenza (H1N1), it was observed that the monocyte and macrophage 
development was defective, but could be stimulated with the administration of a cytokine 
macrophage colony-stimulating factor (M-CSF), which led to decreased viral transcription 
factors and increased inflammatory cytokine levels [58].
Liver is the most important organ in human metabolism, including the metabolism of drug 
compounds. The repopulation of host hepatocytes with human cells enables the study of drug 
metabolism, toxicity and interactions in humanized mice [59,60]. A chimeric mouse model was 
developed, where human specific gene expression of several CYPs were observed [61]. 1A1, 
1A2, 2C9, 2D6 and 3A4 were identified to match the donor values. Additionally, the metabolic 
function of the model was evaluated with all the major human CYP enzymes present, including
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2C9 [62]. Drug compounds with known specific metabolic activities were measured with 
microsomes isolated from the chimeric mice. High level of human transplantation was observed 
by monitoring the levels of circulating human albumin. However, high levels of secretory 
complement factors from the transplanted human cells resulted in proteolytic toxicity against 
host organs in both studies [61,62]. Therefore, the model suffers from a relative short life span 
of the mice. Despite the apparent issues, these models can metabolize drug compounds on 
comparable levels with the human liver. Additional improvements have been made with human 
hepatic stem cells to ensure 100 % rate repopulation, which functioned as the actual human 
liver would in metabolizing ketoprofen and debrisoquine [63]. The humanized liver models 
also enable the study of drug compounds, which are inherently toxic to mice, such as 
furosemide [64], which renders them near unusable in standard small animal studies. The 
differences in mouse and human metabolisms are therefore reduced and similar metabolic 
characteristics can be observed, increasing the translational power between human and 
humanized animals.
Another field that has been extensively taken advantage of humanized animals is cancer 
research. The ability to investigate the interactions between tumors and human immune system 
in animal models has given valuable information in tumor immune escape and the effectiveness 
of antibody treatment and immune modulation [55]. For example, a NSG Hu-SRC-SCID model 
was developed for studying immune modulation in cancer treatment and resistance of human 
breast cancer [65]. A fully developed human immune system was observed, with the maturation 
and activation of T-cells in the presence of the tumor. Interleukin-15 (IL-15) treatment induced 
NK-cell activation, indicating potential immune modulation therapeutic possibilities. However, 
many current models have limitations concerning cancer research, such as inadequate tumor 
heterogeneity [66], or the lack of proper cytokine signaling factors [67]. As discussed earlier, 
the innate immune cell development is defective without cytokine enhancement (i.e. only low 
levels of macrophages, monocytes and NK-cells are present) [68]. To overcome this issue, a 
humanized mouse model called MISTRG Hu-SRC-SCID, was developed [69]. The human 
genes encoding the cytokines interleukin-3 (IL-3), M-CSF, granulocyte-macrophage colony-
stimulating factor (GM-CDF) and thrombopoietin (TPO) were knocked in to their respective 
loci. Additionally, a bacterial artificial chromosome (BAC) transgene was utilized to encode 
the human signal regulatory protein alpha (SIRPα) responsible for integrin associated protein 
(CD47) interactions. With the proper signaling mechanics functioning, high and diverse levels 
of innate human immune cells were observed. Humanized patient-derived xenografts (PDX) 
have been suggested to improve tumor heterogeneity [55,66]. The PDX model is an 
advancement of human cell-line derived humanized models as the original complex tumor 
microenvironment can be retained. Despite the ability to recapitulate the complete tumor 
microenvironment, the PDX is limited, as maintaining a fully functional human immune system 
in the host that matches the patient is still a challenge [66].
Humanized animal models have also been used in studying allograft rejection and 
autoimmunity [70,71]. As described earlier, the humanized immune system provides an 
excellent platform for physiologically relevant observations in mice. This has also lead to 
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numerous studies investigating the mechanisms allograft rejection in animal models [70], which 
could provide to be useful in developing treatments and methods to prevent transplant rejection. 
Another example of functional humanized animal model use is the study of underlying 
mechanisms of type 1 diabetes, an autoimmune disease [71]. These models could provide 
insight of the mechanism and onset of the diseases, which would further improve in the 
development of therapies to combat autoimmunity. Therefore, humanized animal models are 
able to mimic the human in vivo environment closely, and are powerful tools to understand 
many mechanisms and processes of human development and diseases, but also provide methods 
to study interactions, such as pharmacodynamics and pharmacokinetics. The understanding of 
these aspects is also essential in designing functional biomaterials.
3 The design of hydrogel biomaterials
While microfluidics and humanized animal models are excellent tools, an alternative approach 
is to engineer ECM-mimicking hydrogels. Additionally, both systems could benefit from 
carefully designed hydrogel biomaterials, such that they bring structure and function into the 
system [72], or act as cell carriers [73]. However, the ECM is a very intricate and complex 
environment with multiple functions in cell interactions and regulation [74]. The ECM is 
responsible for the structural surroundings and various cues, which are mainly composed and 
mediated by collagens, elastins, fibronectins, laminins, proteoglycans and other components 
totaling approximately 300 different proteins (i.e. the matrisome) [75]. Every cell type in the 
human body has a reciprocal effect with the ECM, this interaction can take place either directly 
or indirectly (Figure 3), for example as a direct cell anchoring platform via the interaction of 
actin components in the cytoskeleton or as an indirect interaction via the reservoir of various 
growth factors [76]. The ECM is in a constant cycle of being made by secretory components, 
remodeled and degraded by the cells, depending on the cell type and feedback loops. The 
dynamic interaction therefore defines the cell microenvironment and regulates cell behavior. 
However, it is not necessary to fully mimic the microenvironment and its every single detail, 
as there are design parameters that can be “tuned”. For example, with hydrogels the mechanical 
properties can be adjusted to correlate with the surrounding tissue [77], chemical modifications 
can guide cell behavior [78] and rheological characteristics can be used to affect solute 
diffusivity [79]. These design aspects are discussed in more detail in the following paragraphs.
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Figure 3. Types of cell-ECM interactions in regulating cell behavior. The signaling 
mechanisms of ECM-cytoskeleton anchoring (red), trans-membrane- (yellow) and membrane-
bound (blue) signal transduction and the biochemical gradient (green) guide cell behavior 
through mechanical and biochemical changes in the microenvironment. ECM can also be 
regulated and remodeled by the cell, by secreting new components (not shown) and through 
enzymatic degradation (black). 
Hydrogels are hydrophilic polymer structures that are capable of retaining large amounts of 
water similarly to soft tissue, while remaining structurally stabile [80]. The bound water within 
the polymer network enables the permeation and diffusion of nutrients and secreted molecules. 
The three-dimensional network is formed by entangled insoluble polymer chains with tunable 
properties, through which it is possible to affect the hydrogels mechanical properties (i.e. 
rheology), porosity, biodegradability and biocompatibility. Forces responsible for holding the 
hydrogel structure intact are often based on ionic crosslinking, hydrogen bonding, polymer 
entanglement and hydrophobic effects [81]. Hydrogels that react to external stimuli are loosely 
called “smart” hydrogels [82,83]. In these, external stimuli can produce changes in the network, 
which in turn can modify various properties of the hydrogel. 
Environmentally sensitive hydrogels 
A common form of environment sensitivity in hydrogels is temperature sensitivity [84]. 
Temperature sensitivity is often induced by propyl, methyl and ethyl groups present in the 
polymer chain network. Two widely used temperature-responsive polymers are poly(N-
isopropylacrylamide) (PNIPAAm) and Poly(N,N-diethylacrylamide) (PDEAAm). For 
example, carbon nanotube reinforced PNIPAAm hydrogel was used with cardiac stem cells as 
an injectable transplant in a rat myocardial infarct model [85]. The in-situ implantation was 
enabled by temperature-sensitive gelation of PNIPAAm at above 32°C. Another example is the 
use of PDEAAm to enable temperature controlled molecular recognition [86]. It was observed 
that ligand binding sites could be blocked and unblocked by exploiting the phase transition 
behavior of streptavidin conjugated PDEAAm. At temperatures lower than 20°C, the polymer 
extends and acts as a steric hindrance, therefore preventing the binding of large biotinylated 
proteins. At temperatures higher than 30°C, PDEAAm begins to collapse, enabling the binding 
of large proteins as the steric hindrance is reduced at the binding site. 
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Environmental pH can also be utilized to induce changes in hydrogel polymer structure. Serum 
albumin was used to prepare autologous hydrogels with an oxidative reduction reaction [87].
The albumin hydrogel gelation occurs at near physiological pH (6-8), while its rheological 
properties, swelling and rate of biodegradation, could be controlled by modifying the albumin 
concentration. Albumin hydrogels are biocompatible and biodegradable, and additionally they 
can be fabricated from a material that is derived from the patient’s own serum. Naturally, 
physiological pH and temperature are important features that can be exploited in hydrogel and 
biomaterial design. However, additional environmental cues have been investigated in inducing 
hydrogel reactions.
Hydrogels can be designed to respond to various other external triggers, such as electrical fields 
[88], magnetic fields [89] and light [90]. In these studies, the hydrogels were investigated and 
evaluated in drug delivery and stem cell release/recovery applications. It is important that
responses can be induced by external sources outside the human body. One great example is 
the eye, where the distinct physiological features allow the use of an external source (e.g. light). 
Environmentally sensitive hydrogels in ophthalmic therapy benefit from the availability of this 
external trigger, as it reduces invasiveness, enables temporal control and increases target 
selectivity [91]. Environmental triggers can also provide measures for in situ formation of
implants with the use of injectable hydrogels [92]. However, hydrogels prepared with chemical 
cross-linking can exhibit cytotoxicity, as the reaction residues and initiators can remain within 
the hydrogel without thorough and complete purification processes.
Synthetic and bio-based polymer hydrogels
Biocompatibility is a clear challenge in hydrogel design, as there is a paradox of contradictory 
properties which are both desirable. The paradox arises from the need for the material to be 
inert and non-inert at the same time. A hydrogel needs to be inert in a way that it does not 
invoke host responses against itself, but also must regulate host responses in a distinct and 
rational manner to achieve its full potential (i.e. is bioactive). Many natural, or bio-based, 
hydrogels, such as polysaccharides and polypeptides, are intrinsically physiological, as they are 
derived from or are actual components of in vivo ECM [93]. Collagen is the most abundant 
protein in mammals and has been widely used in biomedical research [94,95]. Collagen 
supports cell adhesion, is biodegradable in vivo and can be used as an autologous material [96].
For example, dopaminergic neuron survivability was significantly increased in a rat model of 
Parkinson’s disease [97]. Dopaminergic neural rat progenitor cells were encapsulated within a 
glial-derived neurotrophic factor loaded collagen hydrogel. The combination of the trophic 
factor and collagen encapsulation resulted in an increased cell efficiency and enhanced motor 
function. Further examples of animal-based hydrogels are fibrin, hyaluronic acid and chitosan. 
Fibrin hydrogels have been widely used as injectable cell carrier scaffolds [98]. Fibrin 
hydrogels are prepared from pooled from plasma, and as such, much like collagen, they can be 
used as autologous materials. Additionally, fibrin self-assembles in situ and therefore possesses 
environmentally responsive properties. 
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Hyaluronic acid and chitosan hydrogels and their derivatives have been used and studied 
individually in biomedical applications for decades [99,100]. However, with the emerging 
“next generation” hydrogels, the tunable properties can be enhanced with co- and multi-
polymer design, such as hyaluronic acid-chitosan (HA/CS)-hydrogel [101]. HA/CS hydrogels 
encapsulated with fibroblasts were prepared for the treatment of abdominal wall defects. The 
hydrogel design was investigated to mimic abdominal wall tissue microenvironment. It was 
observed that the cytokine levels with the HA/CS hydrogel correlated with in vivo tissue in 
wound healing, which was a result of macrophage phenotype modulation. With the use of 
HA/CS hydrogel in an abdominal defect rat model, the trophic factors were significantly up-
regulated and fibroblast/macrophage recruitment was enhanced resulting in promoting host 
ECM regeneration and wound healing. Further applications that could promote clinical uses of 
co-polymeric hydrogel design, is the ability to functionalize existing treatment methods, such 
as surgical operations [102]. This aspect is discussed in more detail in the experimental part of 
this thesis in a functional hydrogel ex vivo suturing performance study (III). Matrigel™ is a 
commercialized “next generation” hydrogel reconstituted originally from mice Englebreth-
Holm-Swarm tumors [103]. It naturally mimics the basement membrane matrix with an 
assortment of ECM components, such as laminin and collagen, and also includes various 
growth factors and proteases. Therefore, it has been widely used for example as a coating for 
cell cultures platforms [104-106], as a reconstituted basement membrane it provides many 
ECM-like attributes. Recently, a natural 3D hepatic structure was fabricated with PDMS molds 
using a viscoelastic lithography method and matrigel-collagen hydrogel mixtures [107]. The rat 
primary hepatocyte and human umbilical vein endothelial cell co-cultures provided improved 
hepatic function in a finely controllable microstructure matrix, which could be utilized in 
studies requiring well defined soft tissue like microenvironments.
Despite the excellent biocompatibility of autologous materials, such as collagen, fibrin and 
hyaluronic acid, these materials are available from a very limited source (i.e. the patient him-
/herself). Additionally, homologous materials or allografts (from donors of the same species) 
carry the risk of transmittable infection agents. Therefore, materials derived from more 
abundant sources are desired. Such materials as alginate, lignin or NFC, have been found to be 
biocompatible in various implantation applications and could be useful as alternative 
biomaterials [108-110]. However, while biocompatibility is a critical property to have, various 
additional features define these materials and their potential use as a biomaterial in biomedical 
applications.
Alginate is an anionic biopolymer generally derived from seaweed. It has been extensively 
studied as an injectable hydrogel for various biomedical purposes, such as cell delivery [111].
Alginate has been demonstrated to have tunable properties. For example, disodium phosphate 
(Na2HPO4) mediated the modulation of physical and mechanical properties of an alginate 
hydrogel [112]. The ability to tune the mechanical properties enables the preparation of 
hydrogels that match their respective characteristics in various tissues. This is an important 
issue, as there are multiple elements in organ function, which are affected by the mechanical 
properties of the ECM [113]. Stiffness, for example, has an important role in cell differentiation 
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and organ morphogenesis. In next generation hydrogels, alginate has been used in a multi-
polymeric hydrogel with gelatin and collagen [114]. The system was designed to mimic corneal 
ECM, where bio-printing was utilized to form specific 3D hydrogel structures. The structures 
were prepared with human corneal epithelial cells (HCEC) encapsulated within the bio-printing 
ink (i.e. the alginate-gelatin-collagen hydrogel), which resulted in faster cell proliferation and
improved the expression of HCEC specific protein markers. With the ability to fabricate finely 
defined structures with tunable mechanical properties, careful hydrogel designs therefore 
enable systems that are able to closely mimic the in vivo environment. For this apparent reason, 
many studies today have focused on finding new materials to further the biomaterials research.
Other plant-derived hydrogels, such as lignin-derived hydrogels and NFC hydrogels, have been 
investigated in biomedical research. Lignin-based hydrogels are typically isolated and produced 
from wood pulp (called the Kraft process) and co-polymerized, for example with cellulose, or 
obtained by chemical cross-linking [115]. However, a newly discovered method also enables 
the biomodification of Kraft processed lignin to synthesize insoluble lignin-based hydrogels 
without chemical cross-linking [116]. With the use of fungi, intermediate lignin polymer 
hydrogels were produced. Afterwards, the intermediate hydrogels were washed with various 
solvents to acquire insoluble lignin hydrogels with different, solvent dependent properties, such 
as swelling and stability of the hydrogel. Another example of lignin-based hydrogels is lignin-
cellulose beads with immobilized lipase [117]. It has been suggested that these beads could be 
utilized in biomedical studies with biocatalytic functions provided by the immobilized 
enzymes.
Nanofibrillar cellulose is a polysaccharide typically isolated from wood pulp or produced with 
bacterial fermentation [118]. Mechanical shearing and enzymatic treatment methods result in 
several micrometers long cellulose fibrils and fibril aggregates typically 3-20 nm thick 
[119,120].The rheological properties of NFC hydrogels are dependent on the fibril 
concentration. However, the storage modulus is relatively frequency independent, which 
indicates that NFC retains its viscoelastic properties even at very low concentrations. This could 
be beneficial in adjusting the mechanical properties to correlate with different tissue types or to 
regulate cell behavior. For example, NFC has been shown to promote cell polarization and 
differentiation in hepatic progenitor cells [121]. This study is discussed in more detail in the 
experimental section of this thesis (I). Additionally, human embryonic stem cell pluripotency 
could be maintained in NFC cultures [122]. This culture system mimics the microenvironment 
of the anatomical stem cell niche, which is the biological location for stem cell regulation. 
Therefore, enabling further utility and flexibility of the stem cell culture, as it can be 
transformed between 3D and 2D, without affecting the in vivo-like cell organization, while the 
differentiation behavior of the stem cells could be adjusted at any step during the cell culture.
However, as mentioned earlier, purely natural hydrogel properties are often controlled by 
adjusting the polymer/fiber concentration. This also causes changes in the hydrogel network 
properties, such as porosity or active site/scaffold fiber density [123]. Additionally, the source 
has a defining effect to the product, especially with hydrogels such as Matrigel™, where the 
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source variability between different production lots has been shown [124]. Therefore, synthetic 
materials could provide means to improve on these issues [123]. Poly(ethylene glycol) (PEG)-
hydrogels are widely used synthetic hydrogels, with properties useful for the hydrogel design, 
such as controllable mechanical properties and tunable matrix network architecture and 
chemical compositions. However, PEG itself is biochemically inert [125]. Therefore, 
modifications have been investigated to improve PEG usage in biomedical and pharmaceutical 
research. For example, PEG hydrogels were prepared by incorporating synthetic protein grafts 
in the matrix structures to induce cell adhesion [126]. In this study, photopolymerization was 
used to prepare PEG-protein grafts, which contained arginylglycylaspartic acid (RGD)-integrin 
and heparin binding sites with two additional sites for plasmin enzyme induced biodegradation. 
In another study, RGD cell adhesion peptides were incorporated with polyvinyl alcohol (PVA)-
hydrogels [127]. PVA itself does not support cell adhesion. However, it was observed that the 
PVA-RGD hydrogels induced fibroblast cell adhesion and ECM protein production. Indeed, 
RGD and various other components, such as  peptides derived from laminin Tyr-Ile-Gly-Ser-
Arg (YIGSR) and Ile-Lys-Val-Ala-Val (IKVAV) and fibronectin derived peptide Pro-His-Ser-
Arg-Asn (PHSRN) have been utilized to control and guide cell behavior in a “dose-dependent” 
manner by adjusting the ligand density, and therefore signal representation available within the 
synthetic hydrogel matrix [128,129].
Synthetic co-polymers have also been utilized in a similar way as with the next generation bio-
based hydrogels. For example, poly(vinylphosphonic acid-co-acrylicacid) (PVPA-co-AA)-
hydrogels were prepared and evaluated as bone-filler materials [130]. PVPA-co-AA binds to 
divalent calcium ions in bone, and was observed to promote osteoblast adhesion and 
proliferation. With the synthetic bone-filler hydrogel design, bone mineralization and formation 
could be induced in bone defects with natural osteoblast function that mimics the bone 
architecture.
The development of both synthetic and bio-based hydrogels has been increasing in biomedical 
research and tissue engineering. Currently, both designs have their advantages and limitations. 
Despite the system design, important factors need to be considered, such as biocompatibility, 
immunogenicity and biodegradability. For example, biodegradation is an ambiguous property 
in many hydrogels; i.e. biodegradation processes in the environment do not necessarily occur 
in the human body. Therefore, the biomaterial needs to be carefully designed based on its 
potential final use.
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4 Biomedical applications of nanofibrillar cellulose
NFC by itself is not digested by human enzymes and does not biodegrade in the human body 
[131], despite being generally regarded as a biodegradable polymer. However, several studies 
have been made to evaluate NFC and ANFC cytotoxicity and immunogenicity [132-137]. These 
studies have shown NFC and ANFC to be well-tolerated biomaterials with no cytotoxic effects, 
and low potential cytotoxicity even at very high fiber concentrations in NFC. Therefore, these 
materials can be characterized as biocompatible, with ANFC being slightly safer based on the 
previous studies. On the other hand, the leaching of non-cellulosic residues arising from the 
bulk processing and purification methods might lead to immunogenicity of cellulosic materials. 
It was recently discovered that non-cellulosic residues induced varying polysaccharide-based
contaminant levels depending on the fabrication method and source material [138]. This also 
suggests that the potential leaching of non-cellulosic materials could be easily avoided by 
utilizing well studied sources and fabrication methods, such as ANFC.
ANFC begins to show gel properties already at a very low 0.09 % (wt/wt) fiber concentration 
and forms well-structured gels at 0.29 % (wt/wt) concentration [139]. It was also observed, that 
pH and salt content greatly affected the gel stability. Additionally, high polymer content (3-6.5
%) ANFC hydrogels retain their functionality and ideal gel properties, such as viscoelasticity 
and shear thinning through rigorous handling methods, such as freeze-drying [140]. The impact 
of freeze-drying on high polymer content ANFC hydrogel rheology and functionality (e.g. drug 
release properties) is discussed in more detail in the experimental part of this thesis (IV). NFC 
and ANFC can be modified chemically relatively easily, which can be used to yield well defined 
characteristics for intricate applications of a wide variety [141]. It has also been shown that 
chemical surface modification of NFC did not advance their toxicological profile, which was 
already observed to be low for cellulose originated nanomaterials [142].
In addition to biocompatibility and outstanding chemical modification capabilities, NFC is 
relatively inexpensive, has great mechanical properties, and is sustainable and readily available. 
These properties make cellulose-based biomaterials excellent candidates for biomedical and 
pharmaceutical applications. For further reference, these applications as discussed are listed on 
Table 1.
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Table 1. Cell culturing and biomedical applications of plant-derived NFC-based materials.
Polymer composition Formulation Application Ref.
NFC Aerogel and film Wound healing [143]
NFC-hemicellulose Composite hydrogel Wound healing [144]
NFC* Surface modified film Antimicrobial film [145]
NFC Cross-linked hydrogel Antimicrobial hydrogel [146]
NFC** Hydrogel bioink Tailor-made wound dressings [147]
NFC NFC wound dressing Wound healing (clinical study) [148]
NFC-alginate Composite hydrogel bioink Cell-laden ear cartilage scaffold [149,150]
NFC-carbon nanotube Conductive hydrogel bioink Neural tissue engineering [151]
NFC-polyvinyl acetate Composite polymer film Self-softening in situ implantation [152]
Plant cellulose tissue De-cellularized scaffold Subcutaneous implantation (in vivo-study) [110]
NFC Hydrogel Injectable in situ implantation (in vivo-study) [153]
ANFC-chitosan Hydrogel Injectable in situ implantation (in vivo-study) [154]
NFC Hydrogel Injectable hydrogel for localized chemotherapy [155,156]
NFC-alginate Composite hydrogel Suture coating for cell therapy (ex vivo-study) [102]
NFC*** Cross-linked thread Stem cell delivery (ex vivo-study) [157]
NFC Hydrogel 3D organoid development [8,9]
NFC Hydrogel 3D cell culture scaffold [121]
NFC Hydrogel 3D culturing of pluripotent stem cells [122]
NFC-RS/P Composite film Bioadhesive film [158]
NFC-PEG Composite hydrogel Mucoadhesion [159]
NFC Aerogel Gastroretentive drug delivery system [160]
(A)NFC-polymer† Composite film Bioadhesive film [161]
NFC-chitin Composite scaffold Bone tissue engineering [162]
NFC-gelatin Composite scaffold Bone tissue engineering [163]
NFC-hydroxyapatite Composite scaffold Bone tissue engineering [164]
CNC-GIC†† Composite dental cement Restorative dentistry [165]
*Octadecyldimethyl(3-trimethoxysilylpropyl)ammonium chloride modified
**Carboxymethylated and periodate oxidated
***Glutaraldehyde cross-linked
†ANFC- and NFC-Pectin, -mucin and -chitosan composites
††CNC acquired from NFC and reinforced with glass ionomer cement (GIC)
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Wound healing
One of the most widely studied biomedical application for NFC (often bacterial cellulose (BC) 
in this case) is wound healing [166]. Wound healing is a complicated process where the skin 
repairs itself in various steps [167]. After the skin is damaged, disturbing the blood vessels, 
platelets attach on the wound site to promote hemostasis. The platelets begin to secrete wound 
healing and chemotactic factors that, for example, promote fibrin and fibroblast activation and 
attract macrophages. After hemostasis, inflammation occurs and recruited macrophages remove 
pathogens, dead and damaged cells and other debris through phagocytosis. New tissue begins 
to grow through neovascularization, epithelization and granulation tissue formation, where 
epithelial cells cover the wound and granulation tissue invades the wound space. Finally, during 
wound maturation, the ECM is reorganized, phenotypic alteration continues until the cells 
achieve their normal state, and excessive cells responsible for the wound healing processes 
undergo apoptosis, leaving behind scar tissue that is mostly acellular.
Hydrogel-based wound dressings have several advantages over traditional gauze dressings, 
such as lower adherence to the wound [168], providing improved wound healing conditions, 
such as suitable swelling properties and high moisture content [169]. Furthermore, they enhance 
the removal of damaged and necrotic tissue and debris through adsorption [170], promoting the 
natural healing processes as described above [171]. BC-based wound healing applications have 
been extensively investigated and reviewed for commercialized products (XCell, Bioprocess, 
and Biofill) already in the market [172-175]. However, plant-derived NFC has not received the 
same level of attention.
In a comprehensive study by Jack et al., plant-derived NFC-based wound dressings were shown 
to have excellent properties for potential wound healing applications [143]. It was observed that 
NFC dressings provided an environment with ideal moisture content to promote wound healing. 
Additionally, it was shown that with different fabrication methods, the porosity and surface 
roughness could be adjusted. These properties were found to be important in affecting the 
adsorption and bacterial anti-adhesion capabilities. NFC dressings did not promote bacterial 
growth nor the secretion of virulence factors. However, hemicellulose reinforced NFC 
dressings have been shown to promote fibroblast proliferation and viability [144], which could 
prove beneficial as fibroblasts have a critical role in natural wound healing [176]. Furthermore, 
NFC matrix supports the fabrication of antimicrobial properties to include an antimicrobial 
effect [145,146], which could further enhance the wound healing potential of NFC dressings. 
Indeed, it has been proposed that tailor-made NFC-antibiotic wound dressings could be 
fabricated with bioprinting [147]. Therefore, as plant-derived NFC shows excellent versatility 
and have fairly low cost, are non-toxic and biocompatible, they could greatly advance the 
wound healing research.
In a clinical use, as of writing this thesis, plant-derived NFC has been utilized only once as a 
wound dressing for the treatment of skin graft donor sites [148]. 9 patients were treated with 
NFC dressings. 5 patients also received comparative treatment with a commercial product 
Suprathel® as a reference, which is considered as the current standard treatment by many 
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clinicians in Finland. NFC was observed to properly attach into the wound bed, and after 
epithelization, the dressing self-detached without patient discomfort. On one patient the 
treatment was discontinued due to infection. However, in the wound healing process, the NFC 
dressings were observed to perform equally with the commercial product Suprathel®.
According to their findings, the NFC dressing was biocompatible and epithelization was 
slightly faster when compared to Suprathel®. However, continuation studies are required to 
investigate the full potential of plant-derived NFC dressings.
Bioprinting
Recent advances in bioprinting technologies and the use of hydrogels as bioinks has enabled 
the design and fabrication of finely defined structures [177-179]. As previously mentioned, 
NFC hydrogel bioinks have been utilized in mimicking corneal ECM and in the fabrication of 
tailor-made wound dressings [114,147]. Another excellent example of a carefully designed use 
of 3D printing is the anatomically correct human ear cartilage tissue structure with NFC-based 
bioink [149]. MRI and CT acquisitions were used as the blueprints for cartilage fabrication. 
Human nasoseptal chondrocytes were used to evaluate cell bioprinting and bioink in vitro
biocompatibility. The bioink preparation and bioprinting processes initially lowered cell 
viability. However, after 7 days of cell culture in the constructs, the viability increased; 
therefore, the bioprinted constructs themselves did not significantly affect cell viability. These 
systems could be utilized in tissue repair where the construct can be fabricated to resemble the 
original tissue before the tissue defect, such as the human ear. Later it was investigated that the 
same constructs support human primary nasal chondrocyte redifferentation, preservation of 
their phenotype and induced the secretion of cartilage specific ECM components [150].
Therefore, resembling the biological formation and growth of natural human cartilage. As the 
cells are harvested from the patient him-/herself, the immunogenicity of the graft could 
potentially be reduced while maintaining the cartilage function and structure to repair the tissue 
defect. Another example of NFC-based bioprinting is the fabrication of a conductive neural 
tissue scaffold [151]. NFC and carbon nanotube composite bioinks were prepared and 3D 
printed as a scaffold to guide neural cell behavior. It was observed that human-derived 
neuroblastoma cell attachment, growth, proliferation and differentiation was affected by the 
conductive NFC-based scaffolds, while the constructs had minimal effect on cell viability. Such 
systems provide a good basis for potential improvements in neural tissue engineering, which 
could further the treatment of currently incurable neuronal diseases, such as Parkinson’s or 
Alzheimer’s disease.
In situ implantation
Another example of a cellulose-based material as a biomedical device in neural tissue 
engineering is cellulose nanocrystal and polyvinyl acetate (CNC-PVAc)-composite, which 
functions as an external stimuli-responsive implantable biomaterial [180]. CNC-PVAc changes 
its mechanical properties in situ when exposed to artificial cerebrospinal fluid. The matrix in 
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its higher tensile strength state (i.e. dry) enables the implantation procedure and then softens 
when in contact with a fluid (i.e. water) to mimic the mechanical properties of the surrounding 
tissue, such as the brain [181]. The design aspect for such reversible stimuli-responsive 
biomaterials originated from sea cucumbers, which are able to change their dermal stiffness 
“on command” [182]. The mechanism was later found and is suspected to be mediated by a 
protein appropriately named as “softenin” [183]. Due to these properties, CNC-PVAc devices 
were implanted into the cerebral cortex of 8 Sprague-Dawley rats [152]. It was shown that the 
devices transformed to mimic the mechanical surroundings of the cortical tissue. The 
advantages of in situ softening CNC-PVAc implants are reduced inflammatory responses and 
glial scarring when compared to conventional stiff implants [184,185]. In situ implantation can 
also be achieved with NFC hydrogels through injections. While external environmental triggers 
can induce hydrogel gelation, as explained earlier, the response process is often too slow [186],
which is impractical for clinical use. The shear-thinning properties, however, enable the 
hydrogel to regain their strong viscoelastic gel structure immediately after the high shear forces 
subside from the injection process. In the experimental part of this thesis, the in situ injectability 
aspect of NFC hydrogel [153] is discussed in more detail and studied in vivo (II). Overall, only 
a few studies have investigated the potential use of plant-derived NFC in implantation as BC is 
generally considered superior over NFC [187]. However, while plant-derived cellulose 
materials are underrepresented, the versatility and much better availability over BC has 
increased its interest in the biomedical field [188].
Bioadhesion
Bioadhesion is another recently emerged topic for NFC-based hydrogels. Bioadhesion is 
acquired through a contact between a hydrated biological layer and the application surface. 
Such applications can be used for controlled drug delivery or local/topical drug administration. 
In a recent study, colon specific drug delivery was achieved with the use of NFC reinforced 
resistant starch/pectin (RS/P) films [158]. BC and NFC were compared, and it was observed 
that NFC provided far better properties as a reinforcing material, such as stronger bioadhesion, 
improved mechanical properties and interaction with the RS/P matrix. Strong bioadhesion was 
acquired, and it was shown that NFC had a better control over the release rate of methotrexate 
than BC. Overall, NFC was shown to be very effective as a reinforcing material to improve the 
functionality and properties of RS/P films. In another study, different nanofibrous blends with 
various polymers were investigated in terms of bioadhesion [159]. It was observed that 
nanofibrillated blends acquired from carboxymethylcellulose (CMC) and PEG had the highest 
potential for a bioadhesive application. Other investigated blends were PEG-alginate, PEG-
polyacrylic acid and PEG by itself. Also, in a recent study light-weight NFC-based aerogels 
were prepared for a bioadhesive drug release application [160]. The aerogels were shown to 
have great mechanical properties and enhanced in vivo bioavailability of bendamustine 
hydrochloride in Wistar rats. Bioavailability was enhanced by a factor of 3.25 and 5.66 when 
compared with oral drug solution and intravenous injection respectively, with a Tmax of 4 h for 
the aerogel formulation vs. the 1 h of oral drug solution. Additionally, Cmax values were slightly 
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lower for the aerogel formulation than oral drug solution. Therefore, with bioadhesive 
formulations, these applications are able to increase the bioavailability of drug compounds 
(especially poorly soluble ones) by increasing the retention time, and additionally avoiding 
adverse effects. NFC and ANFC were also investigated as a local drug releasing bioadhesive 
fomulations (V) in this thesis. This study is discussed in more detail in the experimental part.
Short summary
Plant-derived NFC has great potential in the biomedical field as a versatile biomaterial. The 
versatility of NFC enables the design of various biomedical applications, which could improve 
current treatment methods and provide novel alternative solutions to several challenges. 
Currently, NFC is underrepresented in clinical and in vivo animal studies when compared to 
BC. However, the supporting information built upon the NFC research as a biomaterial, 
warrants more investigations into the use of NFC in practical biomedical applications.
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5 Aims of the study
The objective of this thesis was to investigate different aspects of NFC-based hydrogels as 
functional biomaterials for pharmaceutical and biomedical applications, such as 3D cell culture, 
in situ implantation, suture coating material for cell delivery, controlled drug release and 
bioadhesive films. The characteristics and performance of these applications were evaluated in 
vivo and in vitro. Specific aims were as follows:
1) Fabrication of functional hydrogel biomaterials. (I-V)
2) Characterization of nanofibrillar cellulose as a cell culture biomaterial and delivery 
device for therapeutic use. (I-V)
3) Modification and optimization of hydrogel biomaterials. (II-V)
4) Functionality of fabricated biomaterials as active materials and potential applications. 
(I-V)
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6 Experimental
6.1 Materials (I-V)
Nanofibrillar cellulose (NFC) and anionic carboxylated NFC (ANFC) stock hydrogels: 1.7 % 
NFC (I), 1.6 % NFC (GrowDex®) (II), 1.47 % NFC (GrowDex®) (III), 3.2 % and 6.8 % 
ANFC (FibDex™) (IV) in addition to 1.5 % NFC (GrowDex®) and 2.7 % ANFC (V) were 
provided by UPM, Finland. MaxGel™ (MG), ExtraCel™ (EC), HydroMatrix™ (HM) and 
PuraMatrix™ (PM) were purchased from Sigma-Aldrich, Glycosan biosystems, Sigma-Aldrich 
and BD Biosciences, respectively. Stannous chloride dehydrate solution (Angiocis®) was 
obtained from IBA Molecular, Belgium. The cocaine analogue 123I- β-CIT was purchased from 
MAP Medical Technologies Oy, Finland. Human serum albumin (HSA) and bovine serum 
albumin (BSA) were purchased from Sigma-Aldrich, Finland. 99mTc-pertechnetate was used to 
label NFC (99mTc-NFC) and HSA (99mTc-HSA). Polyethylene glycol 6000 was purchased from 
Fluka, Switzerland. Sodium alginate was obtained from Sigma-Aldrich (W201502, Finland). 
Surgical sutures (Velosorb™ Fast 3-0) were purchased from Covidien, USA. Metronidazole 
(MZ), Nadolol (NAD), FITC-dextrans (tested molecular weights) and trehalose were obtained 
from Sigma-Aldrich. Ketoprofen (KETO) was purchased from Orion Pharma and Lysozyme 
(LZ) from Roche, Germany. Chitosan oligosaccharide lactate (Sigma-Aldrich, USA), mucin 
from bovine submaxillary gland (EMD Millipore, USA) and pectin from apple (Sigma-Aldrich, 
China) were used as mucoadhesive polymers in bioadhesive films. Microcrystalline cellulose
(MCC Avicel PH200) was purchased from FMC BioPolymer, Ireland. Porcine stomach (Type-
II) and bovine submaxillary gland (Type-I) mucins were acquired from Sigma-Adrich, USA.
Cell lines
Human liver progenitor cells, HepaRG, were cultured in William's E medium supplemented 
with 10% FCS, 1 % penicillin/streptomycin, 5 μg/ml insulin, and 5 x 10-5 M hydrocortisone 
hemisuccinate. Human ARPE-19 cells (ATCC® CRL-2302™, USA), were cultured in 
DMEM-F12 supplemented with with 10 % fetal bovine serum (FBS), 2 mM L-glutamine, 1 % 
penicillin/streptomycin (I).
Human hepatocellular carcinoma cells, HepG2 (ATCC® HB-8065™, USA) and human 
adenocarcinoma-derived endothelial cells, SK-HEP-1 (ATCC® HTB-52™, USA) were 
cultured in high glucose DMEM supplemented with 10 % FBS, 2mM L-glutamine, 1 % 
penicillin/streptomycin and 100 mM sodium pyruvate (I, III).
Human squamous cell carcinoma cells, TR146 (Sigma-Aldich, 10032305, ECACC, UK), were 
cultured in DMEM-F12 supplemented with 10 % FBS and 2 mM GlutaMAX™ (Thermo 
Fisher, USA) (V).
All cells were cultured at 37°C and 5 % CO2. After reaching 70-80 % confluency, the cells were 
passaged (I, III, V).
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6.2 Nanofibrillar cellulose biomaterial fabrication (I-V)
All NFC and ANFC hydrogels were purified and homogenized from aseptically collected wood 
pulp with sterile machinery by UPM. Pulp material was diluted in sterile ultra-high quality 
water prior to fibrillation. Stock hydrogels obtained from fibrillation were autoclaved at 121 °C 
for 20 minutes before cell culturing (I). Afterwards, sterile stock hydrogels were obtained 
directly from UPM (II-V).
1 % 99mTc-NFC hydrogels were prepared with a stannous chloride reduction method for in vivo 
implantation. Radiolabeling efficiency and stability were evaluated with ITLC-SG 
chromatography plates (Agilent Technologies, Santa Clara, CA, USA) in methylethylketone 
(MEK) solvent system. Samples were collected in standard RIA tubes and measured with 
RiaCalc. WIZ, (Wallac 1480 WIZARD® 3" gamma counter, Finland). 5:1 ratio of 1 % NFC 
and saline solutions of 99mTc-HSA, 123I-NaI and 123I-β-CIT were prepared separately for in vivo
SPECT/CT imaging (II).
NFC-alginate (NFCA) hydrogels were prepared for cell culture and surgical suture coatings. 
NFCA hydrogels, composing of 8 % (wt/vol) sodium alginate and 1.35 % (wt/vol) NFC were 
cross-linked with 20 mM barium chloride (Sigma-Aldrich, Finland) and 68 mM calcium 
chloride (Riedel-de-Haen, Germany) solutions and left to settle for 24 h. For cell co-culturing, 
1 mg/ml type-I collagen (Cultrex®, Trevigen USA) was used to enhance cell adhesion on 
NFCA surface (III).
3 % and 6.5 % freeze-dried ANFC aerogels were prepared by snap freezing in liquid nitrogen 
and transferred to FreeZone 2.5 (LabConco, USA) and freeze-dried in 70 mTorr at -52 °C for 
29 h (IV). Prior to diffusion studies and rheological characterization, the freeze-dried samples 
were rehydrated and redispersed with ultra-pure water 1.1 % ANFC cross-linking was 
performed with cationic aluminum sulfate hydrate (Sigma-Aldrich, USA), calcium chloride 
(Sigma-Aldrich, Japan) and iron(III) nitrate nonahydrate (Sigma-Aldrich, Germany). Solid 
powders were dissolved in ANFC and left to settle for 48 h. Concentrations were 2.5 mmol/kg 
for Al3+, 4.4 mmol/kg for Ca2+ and 2.2 mmol/kg for Fe3+ (IV).
Bioadhesive films were prepared by mixing 1 % NFC and ANFC hydrogels with mucoadhesive 
polymers mucin, pectin or chitosan with 2:1 cellulose:mucoadhesive polymer fiber content ratio 
(wt/wt). 10:1 and 1:1 ratios were also used in the bioadhesion measurements. Hydrogel 
mixtures were dried in plastic petri dishes and polylactic acid/teflon molds with a diameter of 
4 cm in both systems at 45 °C for 18 h. Films were prepared with and without MZ. MZ content 
was set to 10 % of dry polymer mass (V).
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6.3 Characterization of NFC hydrogel-based biomaterials (I-V)
Morphology
Scanning electron microscopy (SEM) for NFC hydrogels were performed with JEOL JSM-
7500FA field-emission SEM. Fibril diameters were measured from 300 single fibrils from SEM 
images with the built-in image analysis software. Cryo-transmission electron microscopy was 
performed with field emission cryo-electron microscope (JEOL JEM-3200FSC) operated at 
300 kV.  Micrographs were recorded with Gatan Ultrascan 4000 CCD camera (I).
Freeze-dried ANFC aerogel morphology was investigated with SEM (Quanta FEG250, FEI 
Company, USA). Surface and cross-sectional structures were imaged from fixed samples 
sputtered with platinum (Agar Scientific Ltd., UK) (IV).
NFC and ANFC film morphology with and without mucoadhesive polymers was imaged with 
SEM (Quanta FEG250, FEI Company, USA). Films were fractured and cross-sectional 
micrographs were taken with surface images. Film pieces were fixed and sputtered with 
platinum (Agar Scientific Ltd., UK) (V).
Optical properties
Absorbance of 0.5 % NFC (wt/wt) was measured with UV spectrometer (QuantaMaster™, 
Photon Technology International) at 300-550 nm and fluorescence spectra acquired at 
excitation wavelenghts 405, 488 and 560 nm, using Hoechst 33258, FITC-dextran 70 kDa and 
rhodamine 123 as positive controls and purified water as a negative control (I).
Thermogravimetry
Freeze-dried ANFC aerogel residual water content was measured with TGA 850 (Mettler-
Toledo, Switzerland). Heating rate was set to 10 °C/min (25-240 °C) in nitrogen atmosphere. 
Mass loss (%) parameter was used to evaluate evaporated moisture (IV).
Differential scanning calorimetry
Thermal analysis of ANFC aerogels were performed with DSC 823e (Mettler-Toledo, Giessen, 
Germany). Sealed aluminum pans with closed lids were used and heated at a rate of 10 °C/min 
(25-200 °C) in nitrogen atmosphere. Analysis was performed with STARe software (Mettler-
Toledo, Giessen, Germany). Measurements were performed after one month of storage in silica 
at 20 °C (IV).
Thermal analysis of NFC and ANFC films were performed with DSC 823e (Mettler-Toledo, 
Giessen, Germany). Aluminum pans with perforated lids were used and heated at a rate of 10
°C/min (25-220 °C) in nitrogen atmosphere. Analysis was performed with STARe software 
(Mettler-Toledo, Giessen, Germany) (V).
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Fourier-transform infrared spectroscopy
FTIR spectroscopy was performed using a Vertex 70 FTIR spectrometer (Bruker Optik GmbH, 
Germany) with a MIRacleTM single reflection ATR crystal (Pike Technologies, Inc., USA). The 
analytical range of measurements was 650-4000 cm-1 with a spectral resolution of 4 cm-1. Each 
spectrum was collated as an average of 64 scans with three spectra recorded for each sample 
(V).
Raman spectroscopy
Raman spectroscopy performed for NFC and ANFC films with a Raman RXN1 spectrometer 
(Kaiser Optical systems, Inc., USA), equipped with a PhAt probe and a 20-mW laser source 
operating at 785 nm. Each spectrum was recorded as an average of three scans with an 
integration time of 1 s. For NFC and ANFC control films the parameters were ten scans with 3 
s integration times. Elevated baselines of the spectra were removed and analyzed with Opus 
software (Bruker Optik GmbH, Germany). Before analysis the spectra were normalized by
SNV transformation and mean centering by PCA (SIMCA software, Sartorius Stedim Biotech, 
Sweden) (V).
Rheology
Rheological properties of NFC were investigated at room temperature using a rotational 
rheometer (AR-G2, TA instruments, UK) with 28 mm vane blade geometry and 30 mm 
cylindrical cup. Frequency sweeps were performed with dynamic oscillatory mode at a strain 
of 0.1 %. Viscosity measurements were performed at a shear stress range of 0.01-100 Pa (I).
Rheological properties of NFCA composite hydrogels were measured with Haake™ 
Viscotester™ iQ Rheometer (ThermoFischer, Germany) with 2° cone-plate geometry (35 mm 
in diameter with 0.1 mm gap). Frequency sweeps were performed with a constant amplitude on 
a range of 0.1-20 Hz. Viscosity was measured with controlled rate mode ranging 0.1-1000 1/s 
(III).
1.1 %, ANFC hydrogels (cross-linked and non-cross-linked), 3 % and 6.5 % (hydrogels and re-
hydrated hydrogels) were measured with Viscotester™ iQ Rheometer. Plate-plate geometry (35 
mm in diameter with 1 mm gap) was used. Frequency sweeps were made with a constant 
amplitude on a range of 0.1-20 Hz. Viscosity was measured with controlled rate mode ranging 
0.1-1000 1/s (IV).
All rheological measurements were made in triplicate with a Peltier temperature control system 
set to 25°C (I, III) or to 37 °C (IV).
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Tensile strength of films
20 x 2 mm films were fixed on a measuring table in a humidity controlled tensile tester 
(Kammrath & Weiss GmbH, Germany) with a tensile/compression module of 5 kN and a 100 
N load cell. Young’s modulus (YM), tensile strength, elongation and toughness values were 
measured and calculated form the average of the strain-stress curves. YM was obtained from 
the slope of the elastic region and tensile strength and elongation obtained from the point of 
fracture. Toughness was estimated as the work-of-fracture, by integrating the area under the 
stress curve (V).
Swelling of films
1 cm2 pieces of cellulose:mucoadhesive polymer films were submerged in phosphate buffer 
(6.8 pH) for 15 s and 5 h at room temperature. The weight of the film pieces was measured 
prior and after hydration. Afterwards the films were dried at 45 °C for 20 h and measured again. 
Hydration % and mass loss % were calculated. Additionally, pieces containing MZ were 
immersed for 30 min and film dimensions (thickness and area) were measured prior and after 
hydration with Image J software (National Institutes of Health, Bethesda, USA) (V).
Toxicity
Toxicity study was performed to evaluate NFC/ANFC-mucoadhesive polymer containing film 
cytotoxicity. TR146 cells were incubated with 0.5 cm2 film pieces for 24 h. Film pieces were 
removed and cell proliferation assay (alamarBlue®, Thermo Fisher, USA) was performed with 
Varioskan LUX microplate reader (Thermo Fisher, USA) at 565 nm excitation and 585 nm 
emission wavelengths (V).
6.4 Functionality of hydrogel biomaterials (I-V)
Implantation
NFC hydrogel injectability was evaluated with ARPE-19 cell seeding efficiency test. 2.5*104
cells were seeded in 200 μl of 1.7 % NFC (wt/wt) and cultured for 48 h on a standard 96-well 
cell culture plate. After incubation, the hydrogel samples with the cells were gathered with 1 
ml syringes and transferred into empty wells on a new 96-well plate and cultured for 24 h. 
Various needle sizes (20-27G) were tested when transferring the samples. Cell proliferation 
assay (alamarBlue®, Thermo Fisher, USA) was performed with Varioskan Flash microplate 
reader (Thermo Fisher, USA), excitation and emission wavelengths were 565 nm and 585 nm 
respectively (I).
NFC implants (200 μl) were injected in the pelvic region of 20 female BALB/c mice 
subcutaneous tissue with 123I-NaI, 123I- β-CIT or 99mTc-HSA mixed with the NFC. All mice 
received a dose of 50-60 MBq per implant. SPECT/CT images were acquired with a small 
animal scanner (NanoSPECT/CT®, Bioscan, USA) equipped with multipihole apertures. 
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Image reconstruction was performed with HiSPECT NG software (Scivis GmbH, Germany) 
and fused with the CT acquisitions (InVivoScope™ software, Bioscan Inc., USA). Volumes of 
interests were drawn over thyroid glands, stomach, left kidney, heart, striatum and the site of 
injection. Radioactive decay was corrected and normalized to the time of injection. Finally, 
99mTc-HSA clearance models were made with Phoenix® WinNonlin® (Pharsight, Mountain 
View, USA) (II).
Diffusion and drug release studies
20, 70 and 250 kDa FITC-dextrans were used to model nutrient and macromolecule 
transportation in NFC. 300 μl of NFC hydrogel was pipetted as an even layer (3 mm thick) on 
the apical compartment of 12-well transwell plate and 200 μl of 125 μg/ml FITC-dextrans with 
different molecular weights in PBS were added on top of the hydrogel layer. Samples were 
collected from the basolateral compartment every 15 min for 2 h and afterwards every 30 min 
for 4 h, and replaced with PBS. Samples were measured with Varioskan Flash microplate reader 
(Thermo Fisher, USA), with excitation wavelength of 490 nm and emission wavelength of 530 
nm (I).
Test compounds KETO, MZ, NAD, LZ, 10 kDa FITC-dextran and BSA were used to model 
drug diffusion and release in ANFC hydrogels. 1.1 %, 3 % and 6.5 % (wt/wt) hydrogels were 
thoroughly mixed with test compounds as monolithic solutions. Freeze-dried ANFC hydrogels 
with test compounds KETO, MZ, NAD and BSA contained cryprotectans PEG6000 and 
trehalose. 1.07 g of sample (hydrogel or re-hydrated hydrogel) was placed in a mold with 1.33 
cm2 flat surface area submerged in test buffer (pH 7.4). Hydrogels were kept at constant 
magnetic stirring and samples collected for up to 144 h. Quantification for KETO and NAD 
were measured with ultra-performance liquid chromatography (Acquity UPLC, Waters, USA) 
at the 255 nm and 215 nm wavelengths respectively. FITC-dextran was measured with 
Varioskan Flash at 490 nm excitation and 520 nm emission wavelengths. The absorbance of 
MZ and LZ were analyzed with Cary 100 UV-vis spectrophotometer (Varian Inc., USA) with 
the wavelengths of 320 nm and 280 nm respectively.  BSA was quantified with Bio-Rad protein 
assay (Bio-Rad, USA) based on Bradford dye-binding method (IV).
The release of MZ was measured from 1 cm2 pieces cut from NFC/ANFC-mucoadhesive 
polymer containing films prepared in polylactic acid/Teflon molds. Pieces were submerged in 
release buffer (pH 6.8) and kept under constant magnetic stirring. Samples were collected for 
up to 30 min, filtered and diluted prior to UPLC analysis. Analysis was performed with ultra-
performance liquid chromatography (Acquity UPLC, Waters, USA) at the 317 nm wavelength. 
(V).
Cell culture
HepG2 and HepaRG 3D cell culturing in commercial biomaterials MG, EC, HM and PM was 
performed according to the manufacturer’s instructions, and compared to 3D NFC hydrogel 
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cell cultures in 0.1-1.2 % NFC (wt/wt). Hepatic spheroid formation, morphology, vialibity and 
functionality were evaluated. Cell viability (alamarBlue®), total protein analysis (BCA Protein 
Assay Kit, Pierce Biotechnology, USA) and albumin secretion (Human Albumin ELISA kit, 
Bethyl Laboratories, USA) were all performed according to the manufacturers instruction. 
Confocal microscopy was used to determine hepatic spheroid formation and morphology with 
Alexa Fluor 594 phalloidin (Invitrogen A12381), Hoechst 33258 and fluorescein diacetate 
(Molecular Probes®, USA), using Leica TCS SP5 II HCS A (Leica Microsystems, Germany) 
(I).
HepG2 cells were encapsulated within the NFCA matrix (1043 cells/μl) as a model for 3D 
culture and SK-HEP-1 cells were cultured on the NFCA surface to model 2D monolayer 
culture. Live/Dead confocal imaging was performed with Leica TCS SP5 II HCS A, using 
fluorescein diacetate and propidium iodide (Molecular Probes®, USA) for live and dead cells 
respectively. Cell co-culture dual staining and confocal imaging was performed with 
CellTracker™ Green CMFDA and CellTracker™ Red CMTPX (Molecular Probes®, USA) for 
SK-HEP-1 and HepG2 cells respectively (III).
Surgical suture coatings
NFCA hydrogels with HepG2 cells were prepared in a syringe. A commercial biodegradable 
suture (Velosorb™ Fast) was fed through the needle orifice and NFCA-HepG2 mixture 
extruded on top of the suture as a thin layer (1.5*104 cells/cm/suture). Sutures were cross-linked 
and sewn through pig liver segments and analyzed with confocal microscopy (Leica TCS SP5 
II HCS A). Suturing performance of NFCA coated sutures was investigated in an ex vivo study 
with BALB/c mice and a Wistar rat. Several types of soft tissue (intestine, skin, liver, spleen, 
muscle and testis) were sutured and photographed for evaluation (III).
Bioadhesion
600 g direct compression Type-II mucin/MCC discs with a 4:1 ratio (wt/wt) and 1 % type-I
mucin solutions were prepared for texture analysis (TA.XT plus with a 5 kg load cell, Stable 
Microsystems Ltd.,UK). The disc was attached onto a 10 mm diameter TA.XT plus probe and 
wetted with type-I mucin solution to simulate the mucosa. Films prepared in Petri dishes were 
fixed under the probe, which was lowered at a rate of 0.30 mm/s and a force of 100 g was 
applied on the film surface for 15 s. Peak adhesion force (N) was measured when the probe was 
detached from the film with a retraction speed of 0.30 mm/s. The force required to detach the 
probe was recorded and analyzed with Exponent software (Stable Microsystems Ltd., UK) (V).
 29 
 
7 Results & discussion
NFC-based biomaterial characteristics and applications
In the following experimental part, NFC-based hydrogels were prepared and utilized in various
pharmaceutical and biomedical applications. The main focus was on the applications and their 
functionality. However, some discussion is related to the biomaterial characteristics, when 
appropriate. More detailed information about the hydrogel properties can be found in the 
publications. 
Native NFC rheology and 3D cell culture (I)
The entangled cellulose fibrils formed stable viscoelastic networks typically characterized by a 
high storage modulus (G’) with a lower loss modulus (G’’), while being relatively independent 
of angular frequency [189], as shown in Figure 4A.  It was noticed that the G’ values in relation 
to material stiffness were comparable to a relatively low (1-2 mg/ml) collagen matrix, which 
has been reported to support cell motility [190]. As a pseudoplastic material, NFC was observed 
to follow shear-thinning behavior with increasing shear stress (Figure 4B).
Figure 4. The viscoelastic behavior and shear-thinning of NFC. A) The high ratio of G’ and 
G’’ is relatively independent of angular frequency. B) The shear-thinning effect of different 
concentrations of NFC.
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Shear-thinning is an important property of NFC, as it enables hydrogel injectability. The
viability of ARPE-19 cells was examined after the transfer of cell culture through a syringe 
with various needle sizes up to 27G (inner Ø: 210 μm). The cells remained viable after syringe 
transfer, independent of the inner needle diameter (I, Figure 4). Indicating that NFC hydrogel 
protects and is able to encapsulate the cells safely against the high shear forces of the transfer. 
The shear-thinning effect in the syringe can be described by applying pressure to the hydrogel 
(plunger), which forces the material through the small needle, exposing it to high shear stress. 
NFC transitions into a fluid-like state, which prevents the needle from clogging, therefore 
enabling injectability. Additionally, after the applied force has been lifted, NFC recovers to its 
original viscoelastic state, due to its thixotropic properties. Therefore, the shear-thinning effect 
is reversible, which can be exploited in applications requiring injections and fast gelation 
responses.
NFC was observed to have high viscosity even at below 1% fiber content (Figure 4B). The 
aqueous media bound within the network is therefore very high, which enables the 
transportation of nutrients, waste materials, metabolites and other factors secreted by the cells. 
Therefore, the permeation of various large molecules (20-70 kDa dextrans) was investigated 
through a layer of NFC hydrogel (I, Figure 6A). It was observed that the calculated diffusion 
coefficient values of dextrans (I, Figure 6B), followed similar diffusion behavior as natural 
proteins in ECM [191]. This further suggests that the NFC microenvironment resembles the 
ECM of natural soft tissue in terms of viscoelasticity and molecular diffusion. Additionally, the 
intrinsic high viscosity of NFC polymer fiber network was able to retain the cells as a 
suspension within the matrix (Figure 5A). To evaluate the 3D cell culturing capabilities of NFC, 
hepatic cell morphology and functionality was investigated and compared with various 
commercially available cell culturing hydrogels. It was observed that HepG2 and HepaRG cells 
were able to form multicellular spheroids, which is typical for hepatic morphology (Figure 5B).
The hepatic 3D structure of the spheroids was shown to express cell polarity, often associated 
with bile canaliculi formation [192]. Hepatic differentiation of hepatic progenitor cells HepaRG 
and functionality of HepG2 were examined by measuring cell albumin secretion. Albumin 
secretion increased in HepaRG-NFC cultures during the study period (Figure 5C), which 
indicates hepatic cell differentiation [193]. In HepG2-NFC cultures, the albumin secretion 
remained relatively steady (Figure 5D), which is a common biomarker for HepG2 hepatic 
functionality. Furthermore, it was observed that NFC did not induce cytotoxicity in HepG2 and 
HepaRG cultures (I, Figure 6E-H).
According to these findings, NFC is an excellent platform for a functional 3D cell culture with 
equal or enhanced performance when compared to commercial hydrogels MaxGel™, 
ExtraCel™, HydroMatrix™ and PuraMatrix™. NFC hydrogels were not cytotoxic and are free 
of any animal-based materials. NFC possesses inherent similarities with natural soft tissue and 
forms gels spontaneously without the need for chemical or any other external stimuli, such as 
heat. NFC shear-thinning enables hydrogel injectability, which suggests a potential for a wide 
variety of implantation and cell delivery applications.
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Figure 5. Morphology and functionality of the hepatic cell cultures of HepaRG and HepG2. A-
B) Hepatic cell cultures, filamentous actin (red) and nuclei (blue), in NFC and PuraMatrix™ 
indicate typical spheroid formation with cell polarization. C) HepaRG differentiation as shown 
by increase of albumin secretion during the study. Cultures in NFC and ExtraCel™ were 
observed to express enhanced albumin secretion when compared to other hydrogels. D) HepG2 
albumin secretion in NFC cultures were equal with HydroMatrix™ and ExtraCel™, while 
PuraMatrix™ showed enhanced albumin levels. 
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Native NFC as an injectable implant (II) 
The injectability of plant-derived NFC was investigated and the results indicate that it could be 
used in implantation applications (I). NFC does not require any external sources to invoke a 
gelation response, as it occurs spontaneously. Indeed, many hydrogels require a chemical agent, 
or external stimuli from the environment to achieve gelation. However, these processes are 
often very slow [186], or require toxic cross-linkers [194] and as such are not practical as an 
actual biomedical application. Therefore, NFC hydrogels were used in vivo to study its 
functionality as an in situ drug releasing implant with the use of a small animal dual imaging 
modality single-photon computed tomography/X-ray computed tomography device 
(SPECT/CT) (Figure 6). The aim was to investigate the drug release properties of NFC on small 
(123I-NaI and 123I- β-CIT) and large (99mTc-HSA) molecules in vivo. Specifically, the controlled 
release properties of the large compound 99mTc-HSA. Additionally, it was studied if the 
injectable implant remains intact after administration, as the mice were allowed to move freely 
between the image acquisitions. 
 
 
Figure 6. NFC hydrogels as in situ drug releasing injectable implants. NFC is encapsulated 
with a drug compound, which is then transferred into a syringe. The injection is given to the 
study animals and imaged with SPECT/CT. Both the drug compound and NFC can be traced 
simultaneously with a radiolabel, to investigate the functionality of the implant and evaluate its 
drug release properties. 
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The NFC hydrogels were mixed with either 123I-NaI, 123I- β-CIT or 99mTc-HSA and given as a 
subcutaneous injection to 20 BALB/C mice. Additionally, NFC was radiolabeled and evaluated 
in dual tracing images with the drug compound (Figure 7). It was observed that the small 
molecular drug compounds 123I-NaI and 123I- β-CIT were released rapidly as was noticed from 
the expanse of activity around the implant 15 min post administration. Additionally, the site of 
injection did not show any activity 5 h post administration. It was observed that 123I- β-CIT 
accumulated faster in its target organ (striatum) when given with saline control injections, 
indicating a slightly slower release from the NFC hydrogel. However, the difference in 
accumulated dose was almost negligible. With the larger compound 99mTc-HSA, 41 % of the 
injected dose had been released from the NFC hydrogel 5 h post administration. A 2-fold 
difference was observed in the clearance rate of 99mTc-HSA between NFC and saline sites of 
administration, with the site of NFC being the slower one. This agrees with the finding that the 
NFC matrix hinders the diffusion of large compounds (I). 
 
Figure 7. 123I-NaI and 99mTc-NFC dual trace imaging. The release of 123I-NaI from 99mTc-NFC 
was rapid, as most of the dose has been absorbed from the site of injection at 75 min. White 
circles indicate the NFC implant, which has remained intact during the study period. 
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During the study period, the mice could move freely in their habitats in between the first set, 5 
h and 24 h acquisitions. It was observed that the NFC implants remained intact without any 
signs of deformation or disintegration after the injection. This indicates that the stress caused 
by normal movement is not enough for NFC to transition into the fluid-like state, as was 
described with high shear forces (I).
NFC did not inhibit the release of small molecules when compared with saline injections, 
therefore it can be concluded that no apparent interactions were between the small molecules 
and NFC. The large molecule 99mTc-HSA showed similar inhibition in diffusion as was
observed earlier (I). Therefore, large molecule release rate can be controlled with adjusting the 
NFC fiber content (I, IV). Local or rapid drug release can be achieved with small molecules. 
For example, NFC hydrogels could be spread over a wound with a fast-acting drug molecule to 
achieve immediate treatment, especially if the hydrogel is enhanced with a bioadhesive element 
(V).
Overall, the advantages of NFC implants are injectability and adjustability in terms of fiber 
content. NFC self-gelation occurs immediately after the high shear forces have been lifted, 
therefore no external factors are required to achieve the gel-transition functionality. Potential 
toxicity from cross-linking residues can be avoided completely and the slow gelation response 
is not an issue. Therefore, the system is very simple and easy to use, which makes it readily 
available for any number of in situ implantation applications. However, some challenges remain 
regarding the application. For example, NFC is not biodegradable in the human body and 
despite the chemical modification capabilities, NFC self-degradation in vivo has not been 
extensively studied or explicitly shown. Fortunately, these challenges can be influenced to some 
effect. It was shown that cell cultures could be transferred with a syringe and a needle (I).
Therefore, in the removal of subcutaneous implants, it could be possible to utilize a similar 
technique, i.e. the implant could be removed as it was administered, by injection. Alternatively, 
an additional injection could be administered containing enzymes responsible for cellulose 
degradation. The metabolic products of NFC (mostly glucose) and the enzymes themselves 
have been shown to not induce cytotoxicity [122]. Despite these possibilities, NFC requires 
additional studies as an injectable implant to fully utilize its potential. Therefore, it is suggested 
that currently NFC-based materials are utilized in easily accessible locations, such as under the 
skin (II), as skin patches in e.g. wound healing, or outside of the body, such as the gastro-
intestinal (GI)-tract (III, V).
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NFC-alginate (NFCA) polymer composites in cell delivery (III) 
NFCA composite polymers were prepared to investigate whether it would be a potential system 
for cellular delivery. Alginate was selected for its biocompatibility [195], shear-thinning 
properties [196] and for its gelation ability in the presence of divalent cations [197]. Therefore, 
alginate acted as a gel strength enhancer, while it was desirable to maintain low NFC fiber 
content for optimal 3D cell culture (I). Indeed, the addition of alginate improved the gel strength 
and viscosity significantly, when compared to the native NFC (III, Figure 1-2). For the NFCA 
threads and suture coatings, non-toxic crosslinkers Ca2+ and Ba2+ were used to stabilize the 
hydrogel structure. SK-HEP-1 and HepG2 cells were used as a co-culture in the NFCA 
hydrogels (Figure 8). 
 
Figure 8. HepG2 cell cultures and co-cultures of HepG2 and endothelial SK-HEP-1 cells. A-
B) Spheroid forming HepG2 cells growing on the surface (green) and encapsulated within the 
NFCA matric (red). C-D) SK-HEP-1 cells monolayer formation on the surface (green) and 
HepG2 cells within the matrix (red). Typical morphologies of their respective cell types were 
observed. 
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Surgical suture coatings were prepared with NFCA to cover a synthetic biogradable surgical 
suture. HepG2 cells were encapsulated within the NFCA matrix and sewn through pig liver 
segments to demonstrate cell delivery potential (Figure 9 A-B). The sutures coated with NFCA 
were used in an ex vivo study to investigate suturing performance (Figure 9 C-E). Various soft 
tissue of BALB/C mice and a Wistar rat were sutured and completed with knots. 12 out of 14 
attempts were performed succesfully. The failure of suturing was indicated by the peeling off 
of the coating (III, Figure 6D). Peeling off was probably due to the hydrophobic nature of the 
surgical suture. 
 
Figure 9. NFCA coated surgical suture performance tests. HepG2 cells (red) encapsulated 
within the NFCA coating and sewn 3 times through pig liver segments shows A) intact coating 
structure, and B) coating removed from the suture manually. C-E) Various soft tissue sutures 
were made with NFCA coated sutures. 12 out of 14 attempts were successful. 
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The NFCA encapsulated cell cultures remained viable during the whole 2-week study period 
(III, Figure 3), which was expected based on the excellent cell culturing abilities of NFC with 
low fiber content (I). The addition of alginate did not decrease the cell culturing properties of 
the NFCA system. However, it enabled the formation of stronger gels while still retaining shear-
thinning behavior. Shear-thinning was important in the fabrication of the suture coatings, where 
the high shear forces assist in the spreading of the NFCA evenly on top of the suture. NFC self-
responsive gelation was responsible for keeping the structure intact during fabrication, while 
divalent cation cross-linking enabled the use of coated sutures. Cross-linking was used to 
stabilize the coating to withstand the handling and suturing processes of the intended 
application. However, some peeling off was still observed, which was designated as a suturing 
failure in 2 out of 14 attempts. The durability of the coating could potentially be improved with 
further optimization of the fabrication method and with the use of less hydrophobic sutures.
NFCA coated sutures were easily fabricated and used in the suturing process. The sutures bent 
normally, allowing the completion of the sutures with surgical knots. The advantages of this 
application are that the cells remain protected against host responses, it prevents cell 
distribution into unwanted areas and it enables a direct control over the number of cells, which 
are delivered. The amounts required for successful therapeutic delivery and effect is well within 
the capabilities of NFCA systems, as the number of cells used was similar when compared with 
other studies in cell therapy [198,199]. Additionally, the number of cells can be controlled 
within the NFCA by regulating the hydrogel coating thickness and cell seeding density, without 
the need to adjust suture length. Therefore, as suggested previously (II), NFC-based hydrogels 
have excellent potential in cell delivery into easily accessible area, such as the skin. Additional 
potential target applications are diseases in the GI-tract, such as the Crohn’s disease, where 
surgery is often required and cell therapy has been investigated as a treatment method [200-
202]. Therefore, NFCA coatings could prove effective in combining the surgery and cell 
therapy into one treatment method.
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NFC-based biomaterials for controlled drug delivery (IV)
The controlled release properties of high fiber content ANFC and low fiber content cross-linked 
ANFC were evaluated. Additionally, it was investigated if material handling processes, such as 
freeze-drying, impact on the drug release and rheological properties of the hydrogels. 
Furthermore, it was investigated if the use of cryoprotectants (PEG6000 and trehalose) are able 
to assist the preservation of original hydrogel structure upon rehydration of the aerogel. High 
fiber content ANFC viscosity (Figure 10) and storage/loss modulus (IV, Figure 3) changed 
upon freeze-drying and rehydration, probably due to lamellar aggregate formation through 
irreversible hydrogen bonding between the nanofibrils [203]. Therefore, the water used in the 
rehydration process is unable to completely rehydrate the aggregates. However, when 
cryoprotectants were included in the hydrogel mixture, the changes were negligible, as 
indicated by a complete restoration of its viscoelastic properties upon rehydration from the 
aerogel state. The preservation of these properties, especially during freeze-drying, has been a 
challenge for NFC-based materials [204,205]. The success in the new studies can be attributed 
to the cryoprotectants ability to limit aggregate formation of cellulose, therefore preserving the 
structural integrity of ANFC aerogels and enabling a more complete rehydration. This is 
important especially in pharmaceutical applications where the preservation of functional
properties of the formulation (e.g. drug release properties) during the manufacturing processes 
is critical.
The addition of model compounds BSA (1 % wt/wt) and MZ (2 % wt/wt) affected the 
rehydrated rheological properties slightly (Figure 10). However, the addition of other 
compounds NAD (1.7 % wt/wt) and KETO (3.4 % wt/wt) had no discernible effect, which 
indicates that ANFC hydrogel rehydration is relatively insensitive of included drug compounds 
in the hydrogel mixture even at high concentraitons. Therefore, ANFC hydrogels can be loaded 
with excessive amounts of drug molecules with varying properties, which is important in 
utilizing the matrix structure of ANFC hydrogels in controlled drug delivery.
Low fiber content (1.1%) ANFC hydrogels cross-linked with crosslinking cations Al3+ (2.5 
mmol/kg), Ca2+ (4.4 mmol/kg) and Fe3+ (2.2 mmol/kg) showed a significant increase in 
viscosity and storage modulus values (IV, Supplementary Figure S5). Loss modulus values 
were impacted to a lesser degree. However, the cross-linking stabilized to ANFC structure to 
withstand gel breaking at the tested frequencies (i.e. 1.1 % ANFC did not exhibit frequency 
independecy before cross-linking as indicated by the sudden change in loss modulus values at 
higher frequencies). Additionally, depending on the crosslinking cation, higher or lower values 
could be obtained. For example, the highest viscosity, storage and loss moduli were shown with 
Al3+. Fe3+ and Ca2+ had a relavitely similar effects with each other, with Fe3+ having only a
slightly greater impact on ANFC viscosity and loss modulus. This suggests that the viscoelastic 
properties of ANFC can be greatly affected without increasing the polymer fiber content, which 
has been indicated as a challenge for natural polymers [123]. Additionally, the preservation of 
hydrogel structure at high shear forces ensures that the viscoelastic properties remain after 
material handling processes, for example in coating applications (III).
 39 
 
Figure 10. 3 % ANFC and 6.5 % ANFC shear rate viscosities. The effect of freeze-drying 
altered ANFC viscosities when rehydrated from the aerogel form (FD). The inclusion of 
cryoprotectants assisted rehydration and the viscosity values remain similar with the original 
hydrogel (exp). The addition of model compounds (BSA, MZ, NAD and KETO) had a slight or 
no effect on the rehydrated hydrogel viscosities.
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The freeze-drying and rehydration did not affect the drug release properties of ANFC hydrogels 
(Figure 11). It was observed that the ANFC hydrogels did not swell when submerged in the 
buffer during the drug release experiments, therefore the release of mechanism could be 
described according to the Fick’s diffusion [206]. Additionally, while the hydrogel structure is 
important in controlling the release rate of drug compounds, the release of small molecules 
remain relatively unaffected by the changes in fiber content, as the amount of water bound 
within the system is still very high. The release of larger molecules can be somewhat more 
effectively controlled as it was shown with BSA and LZ (IV, Figure 4 A, C) and agrees with 
earlier discussion (I).
Figure 11. Drug release properties of ANFC hydrogels before and after freeze-drying. A) 3 % 
ANFC hydrogels with drug compounds. B) 6.5 % ANFC hydrogels with drug compounds. No 
significant differences in the drug release properties were observed when aerogels were 
rehydrated.
The effect of rehydration (Figure 11) and cross-linking (IV, Supplementary Figure S6) did not 
have any significant effect on the drug release properties of ANFC. With the use of 
cryoprotectants, ANFC hydrogels could be utilized in biomedical applications, which require 
freeze-drying processes, such as in preserving biological material, or simply to improve the 
shelf-life of sensitive compounds by keeping them in a dry state. It is important that the 
rheological characteristics can be completely restored, while the functionality remains 
unaffected. For example, cell culturing materials (I) or injectable in situ forming drug releasing 
implants (II) could be manufactured and stored safely until use, which would improve both 
shelf-life and logistics. This study further improves the understanding of the versatility of NFC-
based materials, which could help to overcome previously daunting challenges related to the 
use of natural polymers.
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NFC-based application in bioadhesion (V) 
Bioadhesion is an important property of biological membranes. This property can be exploited 
in applications where adhesion to tissue or mucosa is preferable. This study focused on 
improving the bioadhesion properties of NFC, by incorporating mucoadhesive components 
within the matrix and therefore enabling the fabrication of bioadhesive films (Figure 12). 
Typically, bioadhesive applications are utilized to improve bioavailability by administering the 
application directly at the target site (e.g. wound healing) or by using alternative routes to avoid 
first-pass metabolism, such as a subcutaneous implant (II). These systems can also benefit from 
controlled delivery applications (IV). 
 
Figure 12. Bioadhesion properties of NFC-based films. A) NFC-based films were fabricated, 
and B) tested for their adhesiveness. NFC-mucin and ANFC-pectin were the most adhesive 
combinations. Other combinations were also shown to exhibit increased bioadhesivity when 
compared to pure NFC/ANFC and parafilm as the negative control films. 
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The adhesiveness of NFC films was greatly enhanced with the addition of mucoadhesive 
components (pectin, mucin or chitosan). Most adhesive combinations were NFC-mucin and 
ANFC-pectin. It is known that pectin can interact with cellulose, especially with the 
hemicelluloses present in the native NFC [207]. Therefore, all groups available for hydrogen 
bonding in the mucoadhesion process are not available and instead are spent in NFC-pectin 
interactions. ANFC hydrogels lack the hemicellulose components; therefore pectin-cellulose 
interactions are limited, resulting in enhanced mucoadhesion. As a cationic polymer, chitosan 
probably acts in a similar fashion, limiting the available groups for hydrogen bonding, relying 
more on polymer entanglement in the adhesion process.
The cytotoxicity and functionality of NFC-based bioadhesive films were also investigated in 
terms of drug release (Figure 13). No cytotoxicity was observed in any polymer combination. 
MZ containing films did induce some cytotoxicity, which agrees with previous literature about 
the toxicity of the drug itself [208].
Figure 13. Drug release properties and cytotoxicity of NFC-based bioadhesive films. A) 
Depending on the formulation 60-85 % of total amount was released before 30 min. B) Film 
formulation affect cytotoxicity. Films containing MZ were observed as slightly cytotoxic.
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Drug release was observed to be fast. All formulations expressed a burst of 20-40 % at the 
beginning of the experiment. This is probably due to MZ crystals dissolving at the surface of 
the films and therefore causing immediate release. The differences between individual 
formulations can be explained with morphological differences, such as film porosity observed 
in SEM migrographs (IV, Figure 3-4). The denser lamellar structure apparent in ANFC 
containing films could explain the slight differences in the released amounts. Additionally, 
films containing pectin swelled considerably more when compared to mucin films (IV, Table 
4). The longer diffusion path most likely resulted in the slower release of MZ in pectin 
formulations.
Overall, NFC-based bioadhesive films were found to be highly adhesive. The films were 
biocompatible when evaluated for cytotoxicity in a TR146 buccal model cell culture. The 
functionality investigated in this study was drug release, which was observed as rapid. The 
potential application for such formulations could be the treatment of periodontal diseases. The 
films are administered on the surface of the oral cavity. Afterwards the film can be removed or 
swallowed, allowing the natural cleansing mechanisms to dispose of the film through the GI-
tract. Formulation options could enable the controlled release of various drug compounds (IV),
or alternatively the mucoadhesive polymer combinations could be implemented to improve 
other NFC-based applications, where it is desirable that the system remains firmly at the target 
location (II, III).
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8 Future prospects
The need for functional biomaterials is growing more each year, as the understanding behind 
pathogenesis and disease states increases with new technologies, such as humanized animal 
models and microfluidics, that are able to study these topics in a physiologically relevant 
human-like environment. This provides more insight for biomaterial design, but also sets 
pressure on the development of more rational and effective biomedical applications. Many of 
these aspects can be handled with the design of next generation hydrogels that incorporate the 
potential of two or more polymer components within the same system. However, many
currently used hydrogels are limited by availability, are animal-based, or require additional 
processing steps to achieve a functional state. Therefore, a suitable base material with all the 
necessary properties would further biomaterials research, if utilized rationally in the biomaterial 
design. Additionally, as the industry grows, more attention is shifted towards environmentally 
friendly “green” hydrogels and biomaterials that come from a sustainable source of safe 
materials free of ecological burden.
NFC is one of these “green” ecological materials, as it is derived from a nigh inexhaustible 
source (i.e. plants) and degrades naturally in the environment. Furthermore, as discussed and 
shown through experimentation in this thesis, many features of NFC can be exploited in 
designing hydrogel-based biomaterials and biomedical applications. NFC offers a base 
ingredient for the next generation hydrogels, as it possesses intrinsic properties that could prove 
advantageous in biomaterial design in the future. The ideal situation includes an easily available 
source of a biocompatible and biodegradable material, which can be sculpted into shape and 
tuned with high precision as the application demands. So far, NFC fits in most of these 
categories, with the exception of biodegradability in vivo. Therefore, there are aspects which 
still limit the use of NFC and require further investigation. Fortunately, NFC provides 
possibilities through chemical modifications, which may yet lead to a discovery of in vivo self-
degrading NFC. Additionally, with the advances in 3D bio-printing technologies, further 
options become available in structural design, as NFC can serve as a bioink.
Plant-derived NFC is currently underrepresented in biomedical application research when 
compared to bacterial cellulose. However, as new chemical modifications and combinations of 
next generation hydrogels are discovered, new functional properties can be implemented and 
utilized. Therefore, future research in new functional biomedical applications is promising for 
the use of plant-derived NFC, and NFC-based biomaterials. As they offer a potential way to 
bridge the gap between in vitro and in vivo, leading to a future of safe and efficient, green 
biomaterials.
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9 Conclusions
Plant-derived nanofibrillar cellulose (NFC) is a versatile biomaterial with various potential uses 
as a biomedical application. NFC possesses intrinsic physical and mechanical properties that 
resemble in vivo-like microenvironment, which can be further tuned and modified with the 
addition of other polymers, cross-linking agents or by adjusting the fiber content to match the 
properties of the target soft tissue. Most notably, high water content, material stiffness and 
viscoelastic properties offer an excellent platform for cell culture, therefore providing ideal 
conditions for achieving a natural cell morphology, functionality and preservation of the desired 
phenotype (I). Additionally, NFC is a pseudoplastic material, which enables injectability 
through a reversible shear-thinning behavior. This allows material delivery with minimal 
invasive procedures, such as an implant for drug or cell delivery (II), and it enables fabrication 
processes where shear-thinning is advantageous, such as coating applications (III). The self-
gelation occurs spontaneously, therefore additional cross-linkers or external stimuli are not 
necessary. However, the chemical modification properties enable many additional features, 
such as controlled drug delivery (IV), functionalization, e.g. bioadhesion (V), and fine tuning 
rheological properties without adjusting fiber content. Therefore, plant-derived NFC provides 
great potential for future biomedical applications, due to its biomimetic properties and 
outstanding versatility.
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